Need for Improvement in Current Treatment of Psoriatic Arthritis: Study of an Outpatient Clinic Population

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Journal of Rheumatology

• Publication date

  2017-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.3899/jrheum.160973PMID 28148701
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• New therapies for psoriasis and psoriatic arthritis

  2016cited by this paper
• Ultrasonographic evaluation in psoriatic arthritis is of major importance in evaluating disease activity

  2016cited by this paper
• Minimal Disease Activity and Remission in Psoriatic Arthritis Patients Treated with Anti-TNF-α Drugs

  2016cited by this paper
• Disease activity in psoriatic arthritis (PsA): defining remission and treatment success using the DAPSA score

  2015cited by this paper
• A Comparison of Disease Burden in Rheumatoid Arthritis, Psoriatic Arthritis and Axial Spondyloarthritis

  2015cited by this paper
• European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update

  2015cited by this paper
• Evidence for treating rheumatoid arthritis to target: results of a systematic literature search update

  2015cited by this paper
• Ten years of change in clinical disease status and treatment in rheumatoid arthritis: results based on standardized monitoring of patients in an ordinary outpatient clinic in southern Norway

  2015cited by this paper
• Factors Explaining the Discrepancy Between Physician and Patient Global Assessment of Joint and Skin Disease Activity in Psoriatic Arthritis Patients

  2015cited by this paper
• Measuring psoriatic disease in clinical practice. An expert opinion position paper.

  2015cited by this paper
• The definition of remission in psoriatic arthritis: can this be accurate without assessment of multiple domains?

  2015cited by this paper
• Development of a Disease Activity and Responder Index for Psoriatic Arthritis — Report of the Psoriatic Arthritis Module at OMERACT 11

  2014cited by this paper
• Disease Activity in Psoriatic Arthritis: Comparison of the Discriminative Capacity and Construct Validity of Six Composite Indices in a Real World

  2014influential reference
• Remission criteria and activity indices in psoriatic arthritis

  2014cited by this paper
• Burden of Disease: Psoriasis and Psoriatic Arthritis

  2013cited by this paper
• Treating axial and peripheral spondyloarthritis, including psoriatic arthritis, to target: results of a systematic literature search to support an international treat-to-target recommendation in spondyloarthritis

  2013cited by this paper
• Treating spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, to target: recommendations of an international task force

  2013cited by this paper
• Disparity between ultrasound and clinical findings in psoriatic arthritis

  2013cited by this paper
• The development of candidate composite disease activity and responder indices for psoriatic arthritis (GRACE project)

  2012cited by this paper
• Measuring Disease Activity in Psoriatic Arthritis

  2012cited by this paper
• Work disability in psoriatic arthritis: a systematic review.

  2012cited by this paper
• Differences in activity limitation, pain intensity, and global health in patients with rheumatoid arthritis in Sweden and the USA: a 5-year follow-up

  2011cited by this paper
• Finalisation and validation of the rheumatoid arthritis impact of disease score, a patient-derived composite measure of impact of rheumatoid arthritis: a EULAR initiative

  2011cited by this paper
• Development of a preliminary composite disease activity index in psoriatic arthritis

  2010cited by this paper
• Identification of Cutpoints for Acceptable Health Status and Important Improvement in Patient-Reported Outcomes, in Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis

  2010cited by this paper
• Application of the DAREA/DAPSA score for assessment of disease activity in psoriatic arthritis

  2010cited by this paper
• Validation of minimal disease activity criteria for psoriatic arthritis using interventional trial data

  2010cited by this paper
• Measuring clinical enthesitis in psoriatic arthritis: assessment of existing measures and development of an instrument specific to psoriatic arthritis.

  2008cited by this paper
• Validation of the 28-joint Disease Activity Score (DAS28) and European League Against Rheumatism response criteria based on C-reactive protein against disease progression in patients with rheumatoid arthritis, and comparison with the DAS28 based on erythrocyte sedimentation rate

  2008cited by this paper
• Minimal clinically important improvement/difference (MCII/MCID) and patient acceptable symptom state (PASS): what do these concepts mean?

  2007cited by this paper
• Classification criteria for psoriatic arthritis: development of new criteria from a large international study.

  2006cited by this paper
• The Simplified Disease Activity Index (SDAI) and the Clinical Disease Activity Index (CDAI): a review of their usefulness and validity in rheumatoid arthritis.

  2005cited by this paper
• Psoriatic arthritis: epidemiology, clinical features, course, and outcome

  2005cited by this paper
• Development of the ASQoL: a quality of life instrument specific to ankylosing spondylitis

  2003cited by this paper
• Assessment of enthesitis in ankylosing spondylitis

  2003cited by this paper
• Assessment of disability with the World Health Organisation Disability Assessment Schedule II in patients with ankylosing spondylitis

  2003cited by this paper
• Comparison of disability and quality of life in rheumatoid and psoriatic arthritis.

  2001cited by this paper
• Health-related quality of life in patients with psoriasis and atopic dermatitis measured with SF-36, DLQI and a subjective measure of disease activity.

  2000cited by this paper
• A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index.

  1994cited by this paper
• Dermatology Life Quality Index (DLQI)—a simple practical measure for routine clinical use

  1994cited by this paper
• A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index.

  1994cited by this paper
• THE MOS 36- ITEM SHORT FORM HEALTH SURVEY (SF- 36) CONCEPTUAL FRAMEWORK AND ITEM SELECTION

  1992cited by this paper
• The MOS 36-ltem Short-Form Health Survey (SF-36): I. Conceptual Framework and Item Selection

  1992cited by this paper
• The MOS 36-Item Short-Form Health Survey (SF-36)

  1992cited by this paper
• Assessment of patient satisfaction in activities of daily living using a modified Stanford Health Assessment Questionnaire.

  1983cited by this paper
• Measurement of patient outcome in arthritis.

  1980cited by this paper
• Severe psoriasis--oral therapy with a new retinoid.

  1978cited by this paper
• Extended Report

  year unknowncited by this paper

• A Systematic Review of 207 Studies Describing Validation Aspects of the Dermatology Life Quality Index

  2024cites this paper
• Clinical Validation of Digitally Acquired Clinical Data and Machine Learning Models for Remote Measurement of Psoriasis and Psoriatic Arthritis: A Proof-of-Concept Study

  2024cites this paper
• The Efficacy and Safety of Bimekizumab for Plaque Psoriasis: An Expert Consensus Panel

  2024cites this paper
• Exploring 5-year changes in general and skin health-related quality of life in psoriatic arthritis patients

  2024cites this paper
• Biological therapy in psoriatic arthritis patients with and without previous biologic experience

  2022cites this paper
• Real‐World Six‐ and Twelve‐Month Drug Retention, Remission, and Response Rates of Secukinumab in 2,017 Patients With Psoriatic Arthritis in Thirteen European Countries

  2021cites this paper
• Perceived influence of health status on sexual activity in patients with psoriatic arthritis

  2020cites this paper
• Prevalence of Psoriatic Arthritis Patients Achieving Minimal Disease Activity in Real-world Studies and Randomized Clinical Trials: Systematic Review with Metaanalysis

  2020cites this paper
• Impact of skin, musculoskeletal and psychosocial aspects on quality of life in psoriatic arthritis patients: A cross-sectional study of outpatient clinic patients in the biologic treatment era

  2020cites this paper
• Psoriatic arthritis: exploring the occurrence of sleep disturbances, fatigue, and depression and their correlates

  2020cites this paper
• Comorbidities, pain and fatigue in psoriatic arthritis, psoriasis and healthy controls: a clinical cohort study.

  2020influential citation
• Measuring disease activity in psoriatic arthritis: PASDAS implementation in a tightly monitored cohort reveals residual disease burden.

  2020cites this paper
• Comparison of disease activity measures in early psoriatic arthritis in usual care

  2019cites this paper
• Prevalence of minimal disease activity in Australian patients with Psoriatic Arthritis: Assessing the outcome of national funding criteria for biologic disease‐modifying antirheumatic drug prescribing

  2018cites this paper
• Burden of Psoriatic Arthritis According to Different Definitions of Disease Activity: Comparing Minimal Disease Activity and the Disease Activity Index for Psoriatic Arthritis

  2018cites this paper
• Ten years of follow-up data in psoriatic arthritis: results based on standardized monitoring of patients in an ordinary outpatient clinic in southern Norway

  2018influential citation
• Osteoporosis in psoriatic arthritis: a cross-sectional study of an outpatient clinic population

  2018cites this paper
• Ustekinumab in psoriatic arthritis: need for studies from real-world evidence

  2018cites this paper
• Residual disease activity and treatment adjustments in psoriatic arthritis in current clinical practice

  2017cites this paper